The DOI matches its Crossref record; 6 of the 10 references it cites were found in a registry or an index.
Increases in Drug and Opioid Overdose Deaths — United States, 2000–2014
Open accessAbstract
The United States is experiencing an epidemic of drug overdose (poisoning) deaths. Since 2000, the rate of deaths from drug overdoses has increased 137%, including a 200% increase in the rate of overdose deaths involving opioids (opioid pain relievers and heroin). CDC analyzed recent multiple cause-of-death mortality data to examine current trends and characteristics of drug overdose deaths, including the types of opioids associated with drug overdose deaths. During 2014, a total of 47,055 drug overdose deaths occurred in the United States, representing a 1-year increase of 6.5%, from 13.8 per 100,000 persons in 2013 to 14.7 per 100,000 persons in 2014. The rate of drug overdose deaths increased significantly for both sexes, persons aged 25-44 years and ≥55 years, non-Hispanic whites and non-Hispanic blacks, and in the Northeastern, Midwestern, and Southern regions of the United States. Rates of opioid overdose deaths also increased significantly, from 7.9 per 100,000 in 2013 to 9.0 per 100,000 in 2014, a 14% increase. Historically, CDC has programmatically characterized all opioid pain reliever deaths (natural and semisynthetic opioids, methadone, and other synthetic opioids) as "prescription" opioid overdoses (1). Between 2013 and 2014, the age-adjusted rate of death involving methadone remained unchanged; however, the age-adjusted rate of death involving natural and semisynthetic opioid pain relievers, heroin, and synthetic opioids, other than methadone (e.g., fentanyl) increased 9%, 26%, and 80%, respectively. The sharp increase in deaths involving synthetic opioids, other than methadone, in 2014 coincided with law enforcement reports of increased availability of illicitly manufactured fentanyl, a synthetic opioid; however, illicitly manufactured fentanyl cannot be distinguished from prescription fentanyl in death certificate data. These findings indicate that the opioid overdose epidemic is worsening. There is a need for continued action to prevent opioid abuse, dependence, and death, improve treatment capacity for opioid use disorders, and reduce the supply of illicit opioids, particularly heroin and illicit fentanyl.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Opioids accounted for 61% of all drug-related overdoses in 2014 (1).”
From A Biopsychosocial Overview of the Opioid Crisis: Considering Nutrition and Gastrointestinal Health (2019) · cites this paper as [1]
In the citing paper
“Between 2000 and 2014, nearly a half million people in the US died from a drug overdose (1).”
From A Biopsychosocial Overview of the Opioid Crisis: Considering Nutrition and Gastrointestinal Health (2019) · cites this paper as [1]
Citations
Cites
Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008.
Paulozzi, L. J., Jones, C. M., Mack, K. A., & Rudd, R. A. (2011) · PubMed · Cited by 1,350
The Changing Face of Heroin Use in the United States
Cicero, T. J., Ellis, M. S., Surratt, H. L., & Kurtz, S. P. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.366 · Cited by 1,169
Medication-Assisted Therapies — Tackling the Opioid-Overdose Epidemic
Volkow, N. D., Frieden, T. R., Hyde, P. S., & Cha, S. S. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1402780 · Cited by 1,014
Vital Signs: Demographic and Substance Use Trends Among Heroin Users - United States, 2002-2013.
Jones, C. M., Logan, J. E., Gladden, R. M., & Bohm, M. K. (2015) · PubMed Central · Cited by 476
Injury in the United States; 2007 chartbook
Bergen, G., Chen, L., & Warner, M. (2008) · Cited by 120
Davis, G. G. (2013) · Journal of Medical Toxicology · doi:10.1007/s13181-013-0323-x · Cited by 99
Cited by
Sorted by citations
Items 601–700 of 1,001
Carico, R. “., Zhao, X., Thorpe, C. T., Thorpe, J. M., Sileanu, F. E., Cashy, J., Hale, J. A., Mor, M. K., Radomski, T. R., Hausmann, L. R. M., et al. (2018) · Annals of Internal Medicine · doi:10.7326/m18-0852 · Cited by 30
Findings from the Recovery Initiation and Management after Overdose (RIMO) Pilot Study Experiment
Scott, C. K., Dennis, M. L., Grella, C., Nicholson, L., Sumpter, J., Kurz, R., & Funk, R. R. (2019) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2019.08.004 · Cited by 28
Current and Emerging Approaches for Pain Management in Hemophilic Arthropathy
Gualtierotti, R., Tafuri, F., Arcudi, S., Solimeno, L. P., Lozej, J. A., Landi, L., & Peyvandi, F. (2022) · Pain and Therapy · doi:10.1007/s40122-021-00345-x · Cited by 29
“Particularly in low-income countries with limited access to replacement therapy, the associated chronic overuse of opioid drugs is a significant problem, which, however, should not be overlooked, even in high-income countries such as the United States of America (USA), where COXIBs have no indication in hemophilia and…”
BackgroundBrook, J. S., Zhang, C., Rubenstone, E., Primack, B. A., & Brook, D. W. (2016) · Addictive Behaviors · doi:10.1016/j.addbeh.2016.06.003 · Cited by 36
Sokol, R. G., Albanese, C., Chaponis, D. M., Early, J., Maxted, G., Morrill, D., Poirier, G., Puopolo, F., & Schuman‐Olivier, Z. (2017) · Substance Abuse · doi:10.1080/08897077.2017.1356792 · Cited by 29
Parpouchi, M., Moniruzzaman, A., Rezansoff, S. N., Russolillo, A., & Somers, J. M. (2017) · Addictive Behaviors Reports · doi:10.1016/j.abrep.2017.09.001 · Cited by 29
Manual physical therapy for chronic pain: the complex whole is greater than the sum of its parts
Coronado, R. A., & Bialosky, J. E. (2017) · Journal of Manual & Manipulative Therapy · doi:10.1080/10669817.2017.1309344 · Cited by 31
The effect of housing first on adherence to methadone maintenance treatment
Parpouchi, M., Moniruzzaman, A., Rezansoff, S. N., Russolillo, A., & Somers, J. M. (2018) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2018.03.012 · Cited by 29
Freisthler, B., Kepple, N. J., Wolf, J. P., Curry, S. R., & Gregoire, T. (2017) · Children and Youth Services Review · doi:10.1016/j.childyouth.2017.07.014 · Cited by 31
Avoiding Opioid Analgesics for Treatment of Chronic Low Back Pain
Ballantyne, J. C. (2016) · JAMA · doi:10.1001/jama.2016.6753 · Cited by 28
Co-Prescribing Naloxone does not Increase Liability Risk
Davis, C. S., Burris, S. C., Beletsky, L. A., & Binswanger, I. A. (2016) · Substance Abuse · doi:10.1080/08897077.2016.1238431 · Cited by 28
Menie, M. A. W. O., Sarraf, M. A., Pestow, R., & Fernandes, H. B. F. (2017) · Evolutionary Psychological Science · doi:10.1007/s40806-017-0084-x · Cited by 26
Young, H. W., Tyndall, J. A., & Cottler, L. B. (2017) · International Journal of Emergency Medicine · doi:10.1186/s12245-017-0140-0 · Cited by 28
Smith, N., Martins, S. S., Kim, J. M., Rivera‐Aguirre, A., Fink, D. S., Castillo‐Carniglia, Á., Henry, S. G., Mooney, S. J., Marshall, B. D. L., Davis, C. S., et al. (2018) · Addiction · doi:10.1111/add.14440 · Cited by 28
Iwanicki, J. L., Severtson, S. G., Margolin, Z. R., Dasgupta, N., Green, J. L., & Dart, R. C. (2018) · American Journal of Public Health · doi:10.2105/ajph.2018.304728 · Cited by 28
Andereck, J. W., Reuter, Q. R., Allen, K. C., Ansari, S., Quarles, A. R., Cruz, D. S., VanZalen, L., Malik, S., McCarthy, D. M., & Kim, H. S. (2019) · The Joint Commission Journal on Quality and Patient Safety · doi:10.1016/j.jcjq.2019.07.008 · Cited by 27
Thylstrup, B., Seid, A. K., Tjagvad, C., & Hesse, M. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.107714 · Cited by 28
Starr, M. R., Patel, S. V., Bartley, G. B., & Bothun, E. D. (2020) · Ophthalmology · doi:10.1016/j.ophtha.2020.04.015 · Cited by 28
Impact of reported NSAID “allergies” on opioid use disorder in back pain
Li, L., Chang, Y., Song, S., Losina, E., Costenbader, K. H., & Laidlaw, T. M. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.08.025 · Cited by 29
Rao, Y. M., Li, R., Liu, S., Meng, L., Wu, Q., Yuan, Q., Liang, H., & Qin, M. (2021) · Particuology · doi:10.1016/j.partic.2021.11.010 · Cited by 28
How the paediatric workforce can address the opioid crisis
Hadland, S. E., Wood, E., & Levy, S. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31573-2 · Cited by 28
Jeffery, R. M., Dickinson, L., Ng, N. D., DeGeorge, L. M., & Nable, J. V. (2017) · Journal of American College Health · doi:10.1080/07448481.2016.1277730 · Cited by 28
Fentanyl novel derivative‐related deaths
Giorgetti, A., Centola, C., & Giorgetti, R. (2017) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2605 · Cited by 28
McLane, V. D., Bergquist, I., Cormier, J., Barlow, D. J., Houseknecht, K. L., Bilsky, E. J., & Cao, L. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.07.016 · Cited by 28
Aronson, I. D., Bennett, A. S., Marsch, L. A., & Bania, T. C. (2017) · Frontiers in Public Health · doi:10.3389/fpubh.2017.00217 · Cited by 30
High-Risk Prescription Opioid Use Among People Living With HIV
Canan, C. E., Chander, G., Monroe, A. K., Gebo, K. A., Moore, R. D., Agwu, A. L., Alexander, G. C., & Lau, B. M. (2018) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001690 · Cited by 28
“We examined 4 measures of high-risk opioid use: (1)”
InfluentialGoodman‐Meza, D., Medina‐Mora, M. E., Magis-Rodríguez, C. L., Landovitz, R. J., SHOPTAW, S. J., & Werb, D. (2018) · American Journal of Public Health · doi:10.2105/ajph.2018.304767 · Cited by 28
Obeng, S., Jali, A. M., Zheng, Y., Wang, H., Schwienteck, K. L., Chen, C., Stevens, D. L., Akbarali, H. I., Dewey, W. L., Banks, M. L., et al. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00038 · Cited by 30
Mudumbai, S. C., Lewis, E. T., Oliva, E. M., Chung, P. D., Harris, B., Trafton, J. A., Mariano, E. R., Wagner, T. H., Clark, J. D., & Stafford, R. S. (2018) · Pain Medicine · doi:10.1093/pm/pny150 · Cited by 28
Failing health of the United States
Woolf, S. H., & Aron, L. (2018) · BMJ · doi:10.1136/bmj.k496 · Cited by 27
Desensitization and Tolerance of Mu Opioid Receptors on Pontine Kölliker-Fuse Neurons
Levitt, E. S., & Williams, J. T. (2017) · Molecular Pharmacology · doi:10.1124/mol.117.109603 · Cited by 27
“4 Introduction The incidence of prescription opioid overdose has been increasing at a rapid rate in the United States (Centers for Disease Control and Prevention, 2016; Rudd et al., 2016).”
BackgroundInfluentialAre we underestimating the quality of aviremic hepatitis C–positive kidneys? Time to reconsider
Sibulesky, L., Kling, C. E., Blosser, C. D., Johnson, C. K., Limaye, A. P., Bakthavatsalam, R., Leca, N., & Perkins, J. D. (2018) · American Journal of Transplantation · doi:10.1111/ajt.14701 · Cited by 27
Establishment of a pharmacist-led service for patients at high risk for opioid overdose
Tewell, R., Edgerton, L., & Kyle, E. (2018) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp170294 · Cited by 27
Knudsen, H. K., & Studts, J. L. (2018) · The Journal of Behavioral Health Services & Research · doi:10.1007/s11414-018-9629-4 · Cited by 27
Bruneau, J., Arruda, N., Zang, G., Jutras‐Aswad, D., & Roy, É. (2018) · Addiction · doi:10.1111/add.14487 · Cited by 27
Mair, C., Sumetsky, N., Burke, J. G., & Gaidus, A. J. (2018) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2018.79.899 · Cited by 27
Trends in Drug Poisoning Deaths Among Adolescents and Young Adults in the United States, 2006–2015
Ali, B., Fisher, D. A., Miller, T. R., Lawrence, B. A., Spicer, R. S., Swedler, D. I., & Allison, J. (2019) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2019.80.201 · Cited by 28
Zakaria, H. M., Mansour, T. R., Telemi, E., Asmaro, K. P., Bazydlo, M. S., Schultz, L. R., Nerenz, D. R., Abdulhak, M. M., Khalil, J. G., Easton, R. W., et al. (2019) · Neurosurgery · doi:10.1093/neuros/nyz423 · Cited by 27
Hall, O. T., Hall, O. E., McGrath, R. P., & Haile, Z. T. (2019) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000554 · Cited by 27
Pharmacokinetic and pharmacodynamic considerations in developing a response to the opioid epidemic
Balyan, R., Hahn, D., Huang, H. D., & Chidambaran, V. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1721458 · Cited by 29
“Department of Health & Human Services (HHS), there are more than 130 deaths every day from opioid overdose, and almost 400,000 people have died from (any) opioid overdose between 1999 and 2017 [1,2].”
Martins, R. T., Carberry, J. C., Wang, D., Rowsell, L., Grunstein, R. R., & Eckert, D. J. (2020) · European Respiratory Journal · doi:10.1183/13993003.01344-2019 · Cited by 27
Progress in opioid reward research: From a canonical two-neuron hypothesis to two neural circuits
Galaj, E., & Xi, Z. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.173072 · Cited by 29
“Skyrocketing numbers of opioid abuse have greatly contributed to the national opioid epidemic (White House, 2017), taking almost 450,000 American lives since 1999 (CDC, 2020; Colon-Berezin et al., 2019; Gladden et al., 2016; Jannetto et al., 2019; O’Donnell et al., 2017; Rudd et al., 2016).”
Kang, Y., O’Conor, K. A., Kelleher, A. C., Ramsey, J., Bakhoda, A. G., Eisenberg, S. M., Zhao, W., Stodden, T., Pearson, T. D., Guo, M., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-09601-2 · Cited by 25
Xavier, J. C., Greer, A., Pauly, B., Loyal, J. P., Mamdani, Z., Ackermann, E., Barbic, S. P., & Buxton, J. A. (2022) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2022.103714 · Cited by 29
Reduction of opioid use after orthopedic surgery: a scoping review
Gormley, J., Gouveia, K., Sakha, S., Stewart, V., Emmanuel, U., Shehata, M., Tushinski, D. M., Shanthanna, H., & Madden, K. (2022) · Canadian Journal of Surgery · doi:10.1503/cjs.023620 · Cited by 27
The Impact of Naloxone Access Laws on Opioid Overdose Deaths in the U.S.
Erfanian, E., Grossman, D. S., & Collins, A. R. (2019) · Review of Regional Studies · doi:10.52324/001c.7932 · Cited by 27
Opioid-Prescribing Continuity and Risky Opioid Prescriptions
Hallvik, S. E., Geissert, P., Wakeland, W. W., Hildebran, C., Carson, J., O’Kane, N., & Deyo, R. A. (2018) · The Annals of Family Medicine · doi:10.1370/afm.2285 · Cited by 27
Lokala, U., Lamy, F. R., Daniulaityte, R., Sheth, A., Nahhas, R. W., Roden, J. I., Yadav, S., & Carlson, R. G. (2018) · Computational and Mathematical Organization Theory · doi:10.1007/s10588-018-09283-0 · Cited by 27
“Ohio has been identified as one of the high burden states regarding IMF-related overdose mortality (Rudd, 2016; Gladden, 2016; Daniulaityte, Juhascik, et al., 2017).”
BackgroundCarrougher, G. J., Bamer, A. M., Mandell, S. P., Brych, S., Schneider, J. C., Ryan, C. M., Kowalske, K. J., Esselman, P. C., & Gibran, N. S. (2019) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2019.09.009 · Cited by 27
Papp, J., Vallabhaneni, M., Morales, A., & Schrock, J. W. (2019) · BMC Health Services Research · doi:10.1186/s12913-019-4734-5 · Cited by 27
Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit
Kripke, D. F. (2018) · F1000Research · doi:10.12688/f1000research.8729.3 · Cited by 28
Meisel, Z. F., Metlay, J. P., Sinnenberg, L. E., Kilaru, A. S., Grossestreuer, A. V., Barg, F. K., Shofer, F. S., Rhodes, K. V., & Perrone, J. (2016) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2016.03.007 · Cited by 26
“Background The United States and Canada are experiencing an epidemic of prescription drug abuse, with deaths from poisonings exceeding those from motor vehicle crashes since 2008.(1,2) This epidemic is widely acknowledged to be driven”
BackgroundValidation of the Neogen®Fentanyl ELISA Kit for Blood and Urine
Tiscione, N. B., & Wegner, K. (2017) · Journal of Analytical Toxicology · doi:10.1093/jat/bkx005 · Cited by 26
Barth, K. S., Ball, S. J., Adams, R. S., Nikitin, R. V., Wooten, N. R., Qureshi, Z. P., & Larson, M. J. (2017) · Journal of Continuing Education in the Health Professions · doi:10.1097/ceh.0000000000000149 · Cited by 27
Ross, A., Rankin, J., Beaman, J., Murray, K. A., Sinnett, P., Riddle, R., Haskins, J., & Vassar, M. B. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181927 · Cited by 26
Maguire, D. R., & France, C. P. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.11.038 · Cited by 26
Trends in Opioid Use and Prescribing in Medicare, 2006–2012
Axeen, S. (2018) · Health Services Research · doi:10.1111/1475-6773.12846 · Cited by 26
“While the bulk of these deaths occur in the under-65 population, there are high and rising rates of opioid-related overdose among seniors who comprise most of the Medicare population (Rudd et al. 2016).”
BackgroundEvaluating opioid overdose using the National Violent Death Reporting System, 2016
Clinton, H. A., Hunter, A. A., Logan, S. B., & Lapidus, G. D. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.11.002 · Cited by 26
Weiss, R. D., Griffin, M. L., Marcovitz, D. E., Hilton, B. T., Fitzmaurice, G. M., McHugh, R. K., & Carroll, K. M. (2019) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.18m12292 · Cited by 26
Floresta, G., Rescifina, A., & Abbate, V. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092311 · Cited by 27
“In fact, opioid-related overdose deaths due to synthetic opioids are rapidly increasing, augmenting an already established plague to society [7,8].”
BackgroundGicquelais, R. E., Mezuk, B. R., Foxman, B., Thomas, L., & Bohnert, A. S. B. (2019) · Harm Reduction Journal · doi:10.1186/s12954-019-0317-3 · Cited by 26
LeBaron, V. T., CAMACHO, F. T., Balkrishnan, R., Yao, N. A., & Gilson, A. M. (2019) · Journal of Oncology Practice · doi:10.1200/jop.19.00149 · Cited by 26
Mortality among patients with idiopathic intracranial hypertension enrolled in the IH Registry
Hermes, S. M., Miller, N. R., Waslo, C. S., Benes, S. C., & Tanne, E. (2020) · Neurology · doi:10.1212/wnl.0000000000009312 · Cited by 26
Dickson‐Gómez, J., Christenson, E. A., Weeks, M. R., Galletly, C. L., Wogen, J., Spector, A. L., McDonald, M. J., & Ohlrich, J. (2021) · Substance Abuse Research and Treatment · doi:10.1177/1178221821992349 · Cited by 26
Gabapentinoid Use in Perioperative Care and Current Controversies
Patel, A. S., Abrecht, C. R., & Urman, R. D. (2022) · Current Pain and Headache Reports · doi:10.1007/s11916-022-01012-2 · Cited by 26
Soler‐Cedeño, O., & Xi, Z. (2022) · Cells · doi:10.3390/cells11203262 · Cited by 26
“SUD-related costs, including those in crimes, loss of productivity and healthcare, exceed $740 billion per year in the Unites States [1].”
BackgroundSin, B., Tatunchak, T., Paryavi, M., Olivo, M., Mian, U., Ruiz, J. D., Shah, B. K., & de Souza, S. (2017) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2016.12.039 · Cited by 26
Finan, P. H., Remeniuk, B., & Dunn, K. E. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.07.029 · Cited by 27
Prevalence and characteristics of opioid-related deaths involving alcohol in Ontario, Canada
Gomes, T., Juurlink, D. N., Mamdani, M., Paterson, J. M., & van den Brink, W. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.07.008 · Cited by 26
Standard Death Certificates Versus Enhanced Surveillance to Identify Heroin Overdose–Related Deaths
Horon, I. L., Singal, P., Fowler, D. R., & Sharfstein, J. M. (2018) · American Journal of Public Health · doi:10.2105/ajph.2018.304385 · Cited by 28
Risk Factors for Overdose in Treatment-Seeking Youth With Substance Use Disorders
Yule, A. M., Carrellas, N. W., Fitzgerald, M., McKowen, J. W., Nargiso, J. E., Bergman, B. G., Kelly, J. F., & Wilens, T. E. (2018) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.17m11678 · Cited by 26
Dworkis, D. A., Weiner, S. G., Liao, V. T., Rabickow, D., & Goldberg, S. A. (2018) · Western Journal of Emergency Medicine · doi:10.5811/westjem.2018.4.37054 · Cited by 26
Eide, D., Skulberg, A. K., Braarud, A., Dale, O., Heyerdahl, F., Lobmaier, P. P. K., & Clausen, T. (2018) · Substance Abuse · doi:10.1080/08897077.2018.1485130 · Cited by 26
Hser, Y., Saxon, A. J., Mooney, L. J., Miotto, K. A., Zhu, Y., Yoo, C. K., Liang, D., Huang, D. Y. C., & Bell, D. S. (2018) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000458 · Cited by 26
“Previous studies have shown that mortality attributable to prescription drugs decreases with declines in the prescribing rates of drugs (Johnson et al., 2014; Rudd et al., 2016).”
Meisel, Z. F., Mitchell, J., Polsky, D. E., Boualam, N., McGeoch, E. J., Weiner, J., Miclette, M., Purtle, J., Schackman, B. R., & Cannuscio, C. C. (2019) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-019-0199-0 · Cited by 26
Enhanced recovery in liver surgery decreases postoperative outpatient use of opioids
Lillemoe, H. A., Marcus, R. K., Day, R. W., Kim, B. J., Narula, N., Davis, C. H., Gottumukkala, V. N. R., & Aloia, T. A. (2019) · Surgery · doi:10.1016/j.surg.2019.02.008 · Cited by 26
Sigmon, S. C., & Bigelow, G. E. (2016) · Addiction · doi:10.1111/add.13539 · Cited by 26
Powell, D., Pacula, R. L., & Taylor, E. A. (2016) · SSRN Electronic Journal · doi:10.2139/ssrn.2851163 · Cited by 26
Taking Measure of Ohio's Opioid Crisis
Rembert, M., Betz, M., Feng, B., & Partridge, M. D. (2017) · The Knowledge Bank (The Ohio State University) · Cited by 26
Opioid use in children's surgery: Awareness, current state, and advocacy
Bass, K. D., Heiss, K. F., Kelley‐Quon, L. I., & Raval, M. V. (2020) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2020.02.015 · Cited by 29
Benzodiazepine-opioid co-prescribing in a national probability sample of ED encounters
Kim, H. S., McCarthy, D. M., Courtney, D. M., Lank, P. M., & Lambert, B. L. (2016) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2016.11.054 · Cited by 25
“Although the reason for this prescribing pattern is unclear, it is of particular concern given the highest incidence of age-adjusted drug overdose mortality in this age group [17,28].”
Decline and Changing Profile of Hepatitis Delta among Injection Drug users in Spain
Aguilera, A., Trastoy, R., Barreiro, P., Costa, J. J., de Mendoza, C., Peña, J. M., & Soriano, V. (2017) · Antiviral Therapy · doi:10.3851/imp3161 · Cited by 25
Substance Use Disorder Training Workshop for Future Interprofessional Health Care Providers
Monteiro, K. A., Dumenco, L. L., Collins, S. A., Bratberg, J. P., MacDonnell, C. P., Jacobson, A. N., Dollase, R. H., & George, P. (2017) · MedEdPORTAL · doi:10.15766/mep_2374-8265.10576 · Cited by 25
Patterns of opioid use and prescribing for outpatient anorectal operations
Swarup, A., Mathis, K. A., Hill, M. V., & Ivatury, S. J. (2018) · Journal of Surgical Research · doi:10.1016/j.jss.2018.04.005 · Cited by 25
Opioid Prescription Patterns After Rhinoplasty
Sethi, R. K. V., Lee, L. N., Quatela, O. E., Richburg, K., & Shaye, D. A. (2018) · JAMA Facial Plastic Surgery · doi:10.1001/jamafacial.2018.0999 · Cited by 25
Salzman, M., Jones, C. W., Rafeq, R., Gaughan, J., & Haroz, R. (2019) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2019.03.052 · Cited by 25
Effect of Surgery-Specific Opioid-Prescribing Education in a Safety-Net Hospital
Yorkgitis, B. K., Paffett, C., Brat, G. A., & Crandall, M. L. (2019) · Journal of Surgical Research · doi:10.1016/j.jss.2019.05.003 · Cited by 25
Evidence that social-economic factors play an important role in drug overdose deaths
Heyman, G. M., McVicar, N., & Brownell, H. (2019) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2019.07.026 · Cited by 27
Alsabbagh, M. W., Chang, F., Cooke, M. J., Elliott, S. J., & Chen, M. (2021) · Addiction · doi:10.1111/add.15571 · Cited by 25
Broderick, R. C., Li, J. Z., Blitzer, R. R., Ahuja, P., Race, A. J., Yang, G., Sandler, B. J., Horgan, S., & Jacobsen, G. R. (2022) · Surgical Endoscopy · doi:10.1007/s00464-021-08950-9 · Cited by 25
Sheats, K. J., Wilson, R. F., Lyons, B. H., Jack, S. P. D., Betz, C. J., & Fowler, K. A. (2022) · MMWR Surveillance Summaries · doi:10.15585/mmwr.ss7103a1 · Cited by 24
“Opioid overdose has been recognized as an epidemic (22).”
Álvarez-Rodríguez, J., Leirós‐Rodríguez, R., Morera‐Balaguer, J., Marqués‐Sánchez, P., & Rodríguez‐Nogueira, Ó. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12020232 · Cited by 27
Inoue, K., Ritz, B. R., & Arah, O. A. (2022) · Epidemiology · doi:10.1097/ede.0000000000001490 · Cited by 27
Partner Relationships and Injection Sharing Practices among Rural Appalachian Women
Staton, M., Strickland, J. C., Tillson, M. D., Leukefeld, C. G., Webster, J. M., & Oser, C. B. (2017) · Women s Health Issues · doi:10.1016/j.whi.2017.07.005 · Cited by 25
The New York 911 Good Samaritan Law and Opioid Overdose Prevention Among People Who Inject Drugs
Zadoretzky, C., McKnight, C. A., Bramson, H., Jarlais, D. D., Phillips, M., Hammer, M. C., & Cala, M. E. (2017) · World Medical & Health Policy · doi:10.1002/wmh3.234 · Cited by 25
Fink, P. B., Deyo, R. A., Hallvik, S. E., & Hildebran, C. (2017) · Pain Medicine · doi:10.1093/pm/pnx283 · Cited by 25
Jarvis, B. P., Holtyn, A. F., DeFulio, A., Koffarnus, M. N., Leoutsakos, J., Umbricht, A., Fingerhood, M., Bigelow, G. E., & Silverman, K. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.12.026 · Cited by 25
Acupuncture for Acute Pancreatitis
Zhang, K., Gao, C., Li, C., Li, Y., Wang, S., Tang, Q., Zhao, C., & Zhai, J. (2019) · Pancreas · doi:10.1097/mpa.0000000000001399 · Cited by 25
Persistent Opioid Use After Combat Injury and Subsequent Long-term Risk of Abuse
Beyer, C. A., Poltavskiy, E. A., Walker, L. E., Pettey, W. B. P., Suo, Y., Redd, A. M., Rittel, A. G., Kazanis, W. H., Dunham, J. R., Zarzabal, L. A., et al. (2019) · Annals of Surgery · doi:10.1097/sla.0000000000003658 · Cited by 27
Metadata
- Authors
- Rudd, R. A., Aleshire, N., Zibbell, J. E., & Gladden, R. M.
- Affiliations
- National Center for Injury Prevention and Control (US)
- Venue
- MMWR Morbidity and Mortality Weekly Report
- Published
- 2016-01-01
- Volume
- 64
- Issue
- 50-51
- Pages
- 1378-1382
- ISSN
- 0149-2195 (ISSN-L)
- 1545-861X
- OpenAlex
- W2292748019
- Cited by
- 1,859
- References
- 10
- Citations by year
- 2026: 16 · 2025: 35 · 2024: 42 · 2023: 79 · 2022: 118 · 2021: 144 · 2020: 242 · 2019: 271 · 2018: 332 · 2017: 406 · 2016: 169
- FWCI
- 321.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- public-domain
- Locations
- MMWR Morbidity and Mortality Weekly Report (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
- Keywords
- drug overdose deaths, opioid overdose deaths, opioid epidemic, heroin, illicitly manufactured fentanyl, synthetic opioids, methadone, mortality trends, age-adjusted death rates, opioid use disorder, opioid supply
- MeSH terms
- Adolescent, Adult, Aged, Analgesics, Opioid, Child, Child, Preschool, Female, Humans, Infant, Infant, Newborn, Male, Middle Aged, United States, Young Adult, Drug Overdose
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review